AQR Arbitrage’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-667,062
Closed -$7.2M 712
2023
Q3
$7.2M Hold
667,062
0.32% 72
2023
Q2
$7.12M Sell
667,062
-102,965
-13% -$1.09M 0.31% 86
2023
Q1
$8.08M Sell
770,027
-29,966
-4% -$311K 0.25% 118
2022
Q4
$8.21M Hold
799,993
0.21% 140
2022
Q3
$8M Buy
+799,993
New +$8.02M 0.18% 145

Other funds holding RENE

AQR Arbitrage's RENE Position: Q4 2023 in Review

AQR Arbitrage sold out of Cartesian Growth Corp II (RENE) in Q4 2023, closing a stake of 667,062 shares — an estimated $7.2M sold.

AQR Arbitrage first reported a position in RENE in Q3 2022 and held it in 5 quarters. The position peaked at $8.21M in Q4 2022. 34 funds tracked by Wall St. Rank hold RENE as of Q4 2023.

  • AQR Arbitrage reported no remaining Cartesian Growth Corp II position as of Q4 2023 after selling out during the quarter.
  • AQR Arbitrage sold 667,062 Cartesian Growth Corp II shares in Q4 2023, an estimated $7.2M.
  • AQR Arbitrage first reported a position in Cartesian Growth Corp II in Q3 2022 and held it in 5 quarters.
  • AQR Arbitrage's Cartesian Growth Corp II position peaked at $8.21M in Q4 2022.
  • 34 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q4 2023.

Based on AQR Arbitrage's 13F filing for Q4 2023, filed 14 Feb 2024.